UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14C
Information
Statement Pursuant to Section 14(c)
of the Securities Exchange Act of 1934
Check
the appropriate box:
| |
☒ |
Preliminary
Information Statement |
| |
|
|
| |
☐ |
Confidential,
for Use of the Commission Only (as permitted by Rule 14c-5(d)(2)) |
| |
|
|
| |
☐ |
Definitive
Information Statement |
EZFILL
HOLDINGS, INC.
(Name
of Registrant as Specified In Its Charter)
Payment
of Filing Fee (Check the appropriate box):
| |
☒ |
No
fee required |
| |
|
|
| |
☐ |
Fee
paid previously with preliminary materials. |
| |
|
|
| |
☐ |
Fee
computed on table in exhibit required by Item 25(b) of Schedule 14A (17CFR 240.14a-101) per Item 1 of this Schedule and Exchange
Act Rules 14c-5(g) and 0-11 |
EZFILL
HOLDINGS, INC.
67
NE 183rd Street, Miami, Florida 33169
305-791-1169
January
28, 2025
NOTICE
OF WRITTEN CONSENT OF STOCKHOLDERS
WE
ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY
To
the Stockholders of EzFill Holdings, Inc.:
This
Notice and the accompanying Information Statement are being furnished to the stockholders of EzFill Holdings, Inc., a Delaware corporation
(the “Company,” “we,” “us,” or “our”), in connection with
the corporate actions described below taken by the Company’s Board of Directors (“Board”) and by the holders
of a majority of the Company’s voting capital stock. The holders of a majority of the Company’s voting capital stock, by
written consents in lieu of meetings delivered on January 15, 2025, pursuant to Section 228 of the Delaware General Corporation Law (“DGCL”)
and Section 9 of Article II of our bylaws, provided approval for the following corporate actions, respectively (the “Authorizations”):
| |
Item
1. |
Approving
the potential issuance of $500,000 worth of shares of Company common stock to Alcourt LLC under that certain promissory note, dated
as of January 15, 2025, by and between the Company and Alcourt LLC, in the event that such note is not repaid on or before April
15, 2025. Under Nasdaq Listing Rule 5635(d), the Company may not issue shares of Common Stock (or securities convertible into or
exercisable for Common Stock) in other than public offerings without stockholder approval if the aggregate number of shares of Common
Stock issued would be equal to or greater than 20% of the Company’s issued and outstanding shares of Common Stock as of the
date of issuance. |
| |
|
|
| |
Item
2. |
Approving
the potential issuance of $5,000,000 worth of shares of Company common stock to Gad International
Ltd. under that certain promissory note, dated as of December 26, 2024, by and between the
Company and Gad International Ltd., as amended by that certain amendment to promissory note,
dated as of January 15, 2025, in the event that such note is not repaid on or before February
23, 2025. Under Nasdaq Listing Rule 5635(a), listed companies must obtain stockholder approval
prior to the issuance of securities in connection with the acquisition of the stock or assets
of another company if where, due to the present or potential issuance of common stock, including
shares issued pursuant to an earn-out provision or similar type of provision, (i) the common
stock has or will have upon issuance voting power equal to or in excess of 20% of the voting
power outstanding before the issuance of the stock, or (ii) the number of shares of common
stock to be issued is or will be equal to or in excess of 20% of the number of shares of
common stock outstanding before the issuance of the stock. In addition, under Nasdaq Listing
Rule 5635(d), the Company may not issue shares of Common Stock (or securities convertible
into or exercisable for Common Stock) in other than public offerings without stockholder
approval if the aggregate number of shares of Common Stock issued would be equal to or greater
than 20% of the Company’s issued and outstanding shares of Common Stock as of the date
of issuance.
|
| |
Item
3. |
Approving
the potential issuance of up to 4,460,354 shares of Company common stock to NextNRG Holding Corp. under those certain promissory
notes by and between the Company and NextNRG Holding Corp. dated as of November 14, 2024, December 2, 2024, December 3, 2024, December
17, 2024 and December 30, 2024 (collectively, the “Notes”). Under Nasdaq Listing Rule 5635(d), the Company may not issue
shares of Common Stock (or securities convertible into or exercisable for Common Stock) in other than public offerings without stockholder
approval if the aggregate number of shares of Common Stock issued would be equal to or greater than 20% of the Company’s issued
and outstanding shares of Common Stock as of the date of issuance. In addition, Nasdaq Listing Rule 5635(a) requires listed companies
to obtain stockholder approval prior to the issuance of securities in connection with the acquisition of the stock or assets of another
company if any director, officer or substantial shareholder of the listed company has a 5% or greater interest (or such persons collectively
have a 10% or greater interest), directly or indirectly, in the company or assets to be acquired or in the consideration to be paid
in the transaction or series of related transactions and the present or potential issuance of common stock, or securities convertible
into or exercisable for common stock, could result in an increase in outstanding common shares or voting power of 5% or more, which
requirement applies in the case of the potential issuance of shares of the Company’s common stock under the Notes to Mr. Michael
Farkas, who is the beneficial owner of approximately 67.3% of the Company’s issued and outstanding common stock ,
holds more than 5% interest in NextNRG Holding, Corp., and qualifies as a “substantial shareholder” under applicable
Nasdaq rules. |
Concurrently
with the Authorizations, all of the members of the Board, by written consents in lieu of a meeting, as provided under the DGCL, provided
similar authorizations.
This
Information Statement is being furnished to our stockholders of record as of January 15, 2025 , in accordance with Rule 14c-2
under the Securities Exchange Act of 1934, as amended, and the rules promulgated by the Securities and Exchange Commission thereunder,
solely for the purpose of informing our stockholders of the actions taken by the written consent. As the matters set forth in this Information
Statement have been duly authorized and approved by the written consent of the holders of more than a majority of the Company’s
voting securities, your vote or consent is not requested or required to approve these matters. The Information Statement is provided
solely for your information, and also serves the purpose of informing stockholders of the matters described herein pursuant to Section
14(c) of the Securities Exchange Act of 1934, as amended, and the rules and regulations prescribed thereunder, including Regulation 14C.
This Information Statement also serves as the notice required by Section 228 of the DGCL of the taking of a corporate action without
a meeting by less than unanimous written consent of the Company’s stockholders. You do not need to do anything in response to this
Notice and the Information Statement.
The
actions taken by written consent of the majority stockholders will not become effective until the date that is twenty (20) calendar days
after this Information Statement is first mailed or otherwise delivered to holders of our Common Stock as of the Record Date.
THIS
IS NOT A NOTICE OF A MEETING AND NO STOCKHOLDERS’ MEETING WILL BE HELD TO CONSIDER THE MATTERS DESCRIBED HEREIN. WE ARE NOT ASKING
YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND US A PROXY.
| By
Order of the Board of Directors |
|
| |
|
| /s/
Yehuda Levy |
|
| Yehuda
Levy |
|
| |
|
| Interim
Chief Executive Officer |
|
| |
|
| January
28, 2025 |
|
Nasdaq
Requirements
The
Company is subject to the Nasdaq Stock Market’s Listing Rules because our Common Stock is currently listed on the Nasdaq Capital
Market (“Nasdaq”). The issuance of shares of our Common Stock under the agreements described under Items 1 through 3 of this
information statement implicate certain of the Nasdaq listing standards requiring prior stockholder approval in order to maintain our
listing on Nasdaq.
The
foregoing resolutions for the transactions contemplated by the agreements under Items 1 through 3 above are required because under Nasdaq
Listing Rule 5635(d), the Company may not issue shares of Common Stock (or securities convertible into or exercisable for Common Stock)
in other than public offerings without stockholder approval if the aggregate number of shares of Common Stock issued would be equal to
or greater than 20% of the Company’s issued and outstanding shares of Common Stock as of the date of issuance, and the price per
share of Common Stock issued is less than the closing price immediately preceding the signing of the binding agreement or the average
closing price of the Common Stock for the five trading days immediately preceding the signing of the binding agreement (the “Minimum
Price”).
As
a result of the foregoing resolution, on the date which is 20 calendar days after the date of mailing this Information Statement to its
stockholders, the Company will comply with Nasdaq Listing Rule 5635(d), as the resolution will then constitute stockholder approval for
the Company to issue shares of Common Stock to the relevant parties as contemplated by the agreements under Items 1 through 3 above,
in an amount more than 19.99% of the then issued and outstanding Common Stock of the Company, even if the price per share of Common Stock
issued in connection with the transactions is less than the Minimum Price.
Dissenters’
Right of Appraisal
No
dissenters’ or appraisal rights under the DGCL are afforded to the Company’s stockholders as a result of the approval of
the Authorizations.
The
consent we have received constitutes the only stockholder approval required under the DGCL, Nasdaq Listing Rules 5635(a) and 5635(d)
as applicable, our Certificate of Incorporation and our Bylaws, to approve the Authorizations. Our Board is not soliciting your consent
or your proxy in connection with this action and neither consents nor proxies are being requested from stockholders.
Vote
Required
The
vote, which was required to approve the above Authorizations, was the affirmative vote of the holders of a majority of the Company’s
voting stock. Each holder of Common Stock is entitled to one (1) vote for each share of Common Stock held.
The
date used for purposes of determining the number of outstanding shares of the voting stock of the Company entitled to vote to approve
Items 1 through 3 above and the transactions contemplated thereby is January 15, 2025 (the “Voting Record Date”).
The record date for determining those stockholders of the Company entitled to receive this Information Statement is the close of business
on January 15, 2025 (the “Mailing Record Date” ). As of the Voting Record Date, the Company had 6,483,052
shares of voting stock outstanding, with all 6,483,052 shares being Common Stock. All outstanding shares are fully paid
and nonassessable.
Vote
Obtained
Section
228(a) of the DGCL and Section 9 of Article II of our bylaws provide that any action which may be taken at any annual or special meeting
of stockholders may be taken without a meeting, without prior notice and without a vote, via written consent of the holders of outstanding
stock having not less than the minimum number of votes that would be necessary to authorize or take such action at a meeting at which
all shares entitled to vote thereon were present and voted.
The
approximate ownership percentage of the voting stock of the Company as of the Voting Record Date of the consenting stockholders who voted
to approve Items 1 through 3 and the transactions contemplated thereby totaled in the aggregate 63.7%.
Notice
Pursuant to Section 228 of the DGCL
Pursuant
to Section 228 of the DGCL, no advance notice is required to be provided to the other stockholders, who have not consented in writing
to such action, of the taking of the stated corporate action without a meeting of stockholders. No additional action will be undertaken
pursuant to such written consents, and no dissenters’ rights under the DGCL are afforded to the Company’s stockholders as
a result of the action to be taken.
Pursuant
to Section 228 of the DGCL, we are required to provide prompt notice of the taking of corporate action by written consent to our stockholders
who have not consented in writing to such action. This Information Statement serves as the notice required by Section 228 of the DGCL.
TABLE
OF CONTENTS
WE
ARE NOT ASKING YOU FOR A PROXY AND YOU ARE REQUESTED NOT TO SEND A PROXY
ITEM
1.
Approval
of first POTENTIAL ISSUANCE OF COMMON STOCK
On
January 15, 2025, the Company and Alcourt LLC (“Alcourt”) entered into a promissory note (the “January 15 Note”)
for the sum of $1,000,000 to be used for the Company’s working capital needs, including without limitation the purchase of equipment.
The unpaid principal balance of the January 15 Note has a fixed rate of interest of 15% per annum. Further, the January 15 Note is subject
to an original issue discount of $50,000.
Unless
the January 15 Note is otherwise accelerated, or extended in accordance with the terms and conditions therein, the balance of the January
15 Note, along with accrued interest, will be due and payable in full on April 15, 2025 (the “Maturity Date”). If the January
15 Note is not repaid by the Maturity Date, for any reason whatsoever, the Company shall issue shares of its Common Stock with a then
current value of $500,000 to Alcourt (the “Extension Fee”). The shares will be valued based on the greater of: (i) the closing
price of the Company’s common stock on the Maturity Date; or (ii) $1.00 per share; if the Company’s common stock is trading
below $1.00 per share, Alcourt can elect to receive the Extension Fee of $500,000 in cash. Upon payment of the Extension Fee, the Maturity
Date shall be extended until July 15, 2025.
Pursuant
to Nasdaq Listing Rule 5635(d), the Company may not issue shares of Common Stock (or securities convertible into or exercisable for Common
Stock) in other than public offerings without stockholder approval if the aggregate number of shares of Common Stock issued would be
equal to or greater than 20% of the Company’s issued and outstanding shares of Common Stock as of the date of issuance, and the
price per share of Common Stock issued is less than the closing price immediately preceding the signing of the binding agreement or the
average closing price of the Common Stock for the five trading days immediately preceding the signing of the binding agreement (the “Minimum
Price”).
On
January 15, 2025, the Board unanimously approved the potential issuance of $500,000 worth of shares of Company common stock to
Alcourt under the January 15 Note, which may result in shares of common stock issued that is equal or greater than 20% of the Company’s
issued and outstanding shares of common stock as of the date of any such potential issuance. By way of written consents delivered on
January 15, 2025, a majority of the Company’s stockholders holding 4,132,746 shares of our Common Stock representing approximately
63.7% of our voting power approved this Item 1 in accordance with the requirement under Nasdaq Listing Rule 5635(d).
ITEM
2.
Approval
of second POTENTIAL ISSUANCE OF COMMON STOCK
On
December 26, 2024, the Company and Gad International Ltd. (the “Lender”) entered into a promissory note (the “December
26 Note”) for the sum of $2,500,000 (the “Loan”) to be used for the Company’s working capital needs, including
without limitation the purchase of equipment. Under the December 26 Note, the Company agreed to execute an irrevocable transfer instruction
with its transfer agent to issue $5,000,000 worth of shares of Company common stock to the Lender if the December 26 Note is not repaid
on or before February 23, 2025. Such shares of common stock would be valued based on the Nasdaq official closing price for the Company’s
common stock as of date of the issuance of the December 26 Note.
Pursuant
to Nasdaq Listing Rule 5635(a), the Company must obtain stockholder approval prior to the issuance of securities in connection with the
acquisition of the stock or assets of another company if where, due to the present or potential issuance of common stock, including shares
issued pursuant to an earn-out provision or similar type of provision, (i) the common stock has or will have upon issuance voting power
equal to or in excess of 20% of the voting power outstanding before the issuance of the stock, or (ii) the number of shares of common
stock to be issued is or will be equal to or in excess of 20% of the number of shares of common stock outstanding before the issuance
of the stock. In addition, pursuant to Nasdaq Listing Rule 5635(d), the Company may not issue shares of Common Stock (or securities convertible
into or exercisable for Common Stock) in other than public offerings without stockholder approval if the aggregate number of shares of
Common Stock issued would be equal to or greater than 20% of the Company’s issued and outstanding shares of Common Stock as of
the date of issuance, and the price per share of Common Stock issued is less than the closing price immediately preceding the signing
of the binding agreement or the Minimum Price.
On
December 26, 2024, the Board unanimously approved the potential issuance of $5,000,000 worth of shares of Company common
stock to the Lender under the December 26 Note, which may result in shares of common stock issued that is equal or greater than 20% of
the Company’s issued and outstanding shares of common stock as of the date of any such potential issuance. By way of written consents
delivered on January 15, 2025, a majority of the Company’s stockholders holding 4,132,746 shares of our Common Stock representing
approximately 63.7% of our voting power approved this Item 2 in accordance with the requirements under NASDAQ Listing Rules 5635(a) and
5635(d).
ITEM
3.
Approval
of third POTENTIAL ISSUANCES OF COMMON STOCK
As
previously disclosed in certain Current Reports under cover of Form 8-K as identified below and which are hereby incorporated by reference,
the Company entered into certain promissory notes with NextNRG Holding Corp., dated as of November 14, 2024, December 2, 2024, December
3, 2024, December 17, 2024 and December 30, 2024 (collectively, the “Notes”).
Pursuant
to Nasdaq Listing Rule 5635(d), the Company may not issue shares of Common Stock (or securities convertible into or exercisable for Common
Stock) in other than public offerings without stockholder approval if the aggregate number of shares of Common Stock issued would be
equal to or greater than 20% of the Company’s issued and outstanding shares of Common Stock as of the date of issuance, and the
price per share of Common Stock issued is less than the closing price immediately preceding the signing of the binding agreement or the
Minimum Price. In addition, Nasdaq Listing Rule 5635(a) requires listed companies to obtain stockholder approval prior to the issuance
of securities in connection with the acquisition of the stock or assets of another company if any director, officer or substantial shareholder
of the listed company has a 5% or greater interest (or such persons collectively have a 10% or greater interest), directly or indirectly,
in the company or assets to be acquired or in the consideration to be paid in the transaction or series of related transactions and the
present or potential issuance of common stock, or securities convertible into or exercisable for common stock, could result in an increase
in outstanding common shares or voting power of 5% or more, which requirement applies in the case of the potential issuance of shares
of the Company’s common stock under the Notes to Mr. Michael Farkas, who is the beneficial owner of approximately 67.3%
of the Company’s issued and outstanding common stock , holds more than 5% interest in NextNRG Holding, Corp., and qualifies
as a “substantial shareholder” under applicable Nasdaq rules.
On
December 30, 2024, the Board unanimously approved the potential issuance of up to 4,460,354 shares of Company common stock to
NextNRG Holding Corp. under the Notes, which may result in shares of common stock issued that is equal or greater than 20% of the Company’s
issued and outstanding shares of common stock as of the date of any such potential issuance. By way of written consents delivered on
January 15, 2025, a majority of the Company’s stockholders holding 4,132,746 shares of our Common Stock representing approximately
63.7% of our voting power approved this Item 3 in accordance with the requirement under Nasdaq Listing Rules 5635(a) and 5635(d).
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT
The
following table sets forth certain information regarding the ownership of the Company’s common stock as of January 15, 2025
by: (i) each executive officer and director; (ii) all executive officers and directors of the Company as a group; and (iii) all those
known by the Company to be beneficial owners of more than five percent (5%) of its Common Stock.
Unless
otherwise indicated in the footnotes to this table and subject to community property laws where applicable, the Company believes that
each of the stockholders named in this table has sole voting and investment power with respect to the shares indicated as beneficially
owned. Applicable percentages are based on 6,483,052 shares of Common Stock issued and outstanding on January 15, 2025,
adjusted as required by rules promulgated by the SEC.
| Name
of Beneficial Owner (1) | |
Shares of Common Stock Beneficially
Owned | | |
Percentage(2)
| |
| Beneficial Owners of more than 5%: | |
| | | |
| | |
| Michael D. Farkas(3) | |
| 4,852,150 | | |
| 67.3 | % |
| Executive Officers and Directors: | |
| | | |
| | |
| Yehuda Levy | |
| 18,270 | | |
| * | |
| Michael Handelman | |
| 0 | | |
| - | |
| Avi Vaknin | |
| 64,713 | | |
| * | |
| Daniel Arbour | |
| 27,697 | | |
| * | |
| Jack Leibler | |
| 21,886 | | |
| * | |
| Bennett Kurtz | |
| 21,036 | | |
| * | |
| Sean Oppen | |
| 44,755 | | |
| * | |
| | |
| | | |
| | |
| All Officers and Directors as a Group (7 persons) | |
| 198,357 | | |
| 3.05 | % |
*Less
than 1%
| |
(1) |
The
address of each of the officers and directors is 67 NW 183rd St., Miami, Florida 33169; the address of Michael D. Farkas is 1221
Brickell Avenue, Ste. 900, Miami, FL 33131. |
| |
|
|
| |
(2) |
The
calculation in this column is based upon 6,483,052 shares of Common Stock outstanding on January 15, 2025. Beneficial
ownership is determined in accordance with the rules of the SEC and generally includes voting or investment power with respect to
the subject securities. Shares of Common Stock that are currently exercisable or exercisable within 60 days of January 15,
2025 are deemed to be beneficially owned by the person holding such securities for the purpose of computing the percentage beneficial
ownership of such person, but are not treated as outstanding for the purpose of computing the percentage beneficial ownership of
any other person. |
| |
|
|
| |
(3) |
Includes
(i) 154,827 shares of common stock held by SIF Energy LLC, (ii) 3,705,632 shares of common stock held by NextNRG Holding Corp., (iii)
26,578 shares of common stock held by Balance Labs, Inc. Also includes 719,424 shares which may be issued upon the conversion of
140,000 shares of Series B Preferred Stock held by NextNRG Holding Corp., each with a stated value of $10.00 per share, at 70% of
$2.78 (the minimum price on the date of issuance). Michael D. Farkas has voting and investment control of the shares of common stock
held by Farkas Brothers, LLC, SIF Energy LLC, NextNRG Holding Corp and Balance Labs, Inc. |
INTERESTS
OF CERTAIN PERSONS IN THE AUTHORIZATIONS
No
officer, director, nominee for election as a director, associate of any director, executive officer or nominee, or beneficial owner of
more than 5% of our Common Stock has any substantial interest in the matters acted upon by our Board and stockholders, other than his
role as an officer, director or beneficial owner, except that Michael D. Farkas, who is a beneficial owner of more than 5% of our Common
Stock, is the CEO and largest stockholder of NextNRG Holding Corp.
CAUTIONARY
STATEMENT CONCERNING FORWARD-LOOKING INFORMATION
This
Information Statement may contain “forward-looking statements” made under the “safe harbor” provisions of the
Private Securities Litigation Reform Act of 1995. The statements include, but are not limited to, statements concerning the effects of
the stockholder approval and statements using terminology such as “expects,” “should,” “would,” “could,”
“intends,” “plans,” “anticipates,” “believes,” “projects” and “potential.”
Such statements reflect the current view of the Company with respect to future events and are subject to certain risks, uncertainties,
and assumptions. Known and unknown risks, uncertainties and other factors could cause actual results to differ materially from those
contemplated by the statements.
In
evaluating these statements, you should specifically consider various factors that may cause our actual results to differ materially
from any forward-looking statements. These risk factors include the following risk factor relating to the Company’s compliance
with the continued listing requirements of Nasdaq:
ADDITIONAL
INFORMATION
Householding
of Materials
Some
banks, brokers, and other nominee record holders may be participating in the practice of “householding” proxy statements
and annual reports. This means that only one copy of our Information Statement may have been sent to multiple Company stockholders in
each household unless otherwise instructed by such Company stockholders. We will deliver promptly a separate copy of the Information
Statement to any Company stockholder upon written or oral request to us, at Corporate Secretary, EzFill Holdings, Inc., 67 NE 183rd
Street, Miami, FL 33169, or contact (305) 791-1169. Any Company stockholder wishing to receive separate copies of our proxy statement
or annual report to Company stockholders in the future, or any Company stockholder who is receiving multiple copies and would like to
receive only one copy per household, should contact the Company stockholder’s bank, broker, or other nominee record holder, or
the Company stockholder may contact us at the above address and phone number.
Costs
We
will make arrangements with brokerage firms and other custodians, nominees, and fiduciaries who are record holders of our Common Stock
for the forwarding of this Information Statement to the beneficial owners of our Common Stock. We will reimburse these brokers, custodians,
nominees, and fiduciaries for the reasonable out-of-pocket expenses they incur in connection with the forwarding of the Information Statement.
Incorporation
By Reference
The
SEC allows us to “incorporate by reference” information into this Information Statement, which means that we can disclose
important information to you by referring you to other documents that we have filed separately with the SEC and are delivering to you
with a copy of this Information Statement. The information incorporated by reference is deemed to be part of this Information Statement.
This Information Statement incorporates by reference the following documents:
| |
● |
Annual
Report on Form 10-K filed on April
1, 2024. |
| |
|
|
| |
● |
Quarterly
Report for the quarter ended March 31, 2024 on Form
10-Q filed on May 14, 2024. |
| |
|
|
| |
● |
Quarterly
Report for the quarter ended June 30, 2024 on Form
10-Q filed on August 14, 2024. |
| |
|
|
| |
● |
Quarterly
Report for the quarter ended September 30, 2024 on Form
10-Q filed on November 13, 2024. |
| |
|
|
| |
● |
Definitive
Information Statement on Schedule
14C filed on October 11, 2024.
|
| |
● |
Definitive
Proxy Statement on Schedule
14A filed on December 31, 2024, and Definitive Additional Materials on Schedule
14A filed on January 13, 2025.
|
| |
● |
Preliminary
Prospectus on Form
S-1 filed on December 20, 2024, and Post-Effective Amendment No. 1 to Form S-1 filed
on January 22, 2025.
|
| |
● |
Current
Reports on Form 8-K filed by the Company on April
2, 2024, April 9, 2024, April
10, 2024, April 26, 2024, May
14, 2024, May 15, 2024, May
29, 2024, June 3, 2024, June
14, 2024, June 18, 2024, June
21, 2024, June 28, 2024, July
10, 2024, July 15, 2024, July
25, 2024, August 12, 2024, August
15, 2024, August 20, 2024, September
3, 2024, September 27, 2024, November
14, 2024, November 19, 2024,
November 22, 2024, December
5, 2024, December 18, 2024,
December 18, 2024, December
19, 2024, January 2, 2025,
January 3, 2025, January
10, 2025, January 21, 2025,
January 21, 2025, and January 23, 2025. |
You
may read and copy any reports, statements, or other information we file at the public reference facilities maintained by the SEC in Room
1590, 100 F Street, N.E., Washington, D.C. 20549. Please call the SEC at 1-800-SEC-0330 for additional information on the operation of
the SEC’s public reference facilities. The SEC maintains a website that contains reports, proxy statements, and other information,
including those filed by us, at http://www.sec.gov.
Any
statement contained in a document incorporated or deemed to be incorporated by reference in this Information Statement will be deemed
modified, superseded or replaced for purposes of this Information Statement to the extent that a statement contained in this Information
Statement or in any subsequently filed document that also is or is deemed to be incorporated by reference in this Information Statement
modifies, supersedes or replaces such statement.
| By
Order of the Board |
|
| |
|
| /s/
Yehuda Levy |
|
| Yehuda
Levy |
|
| Interim
Chief Executive Officer |
|
| January
28, 2025 |
|
EzFill (NASDAQ:EZFL)
Historical Stock Chart
From Feb 2025 to Mar 2025
EzFill (NASDAQ:EZFL)
Historical Stock Chart
From Mar 2024 to Mar 2025
